Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.110 | ||
| Révision: | $508.00M | $525.40M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.420 | 1.350 | -0.0700 |
| Révision: | $497.00M | $526.70M | $15.80M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.100 | 2.190 | 0.0900 |
| Révision: | $525.00M | $538.80M | -$5.10M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.180 | 1.740 | 0.5600 |
| Révision: | $513.00M | $526.40M | $11.60M |
